Dual inhibition of integrins alpha-v/beta-6 and alpha-v/beta-1 decreases portal pressure and liver fibrosis in rats with biliary cirrhosis
Philipp Königshofer(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Scott Turner(KineMed (United States)), Benedikt Simbrunner(Austrian Academy of Sciences), Hubert Scharnagl(Medical University of Graz), Benedikt Hofer(Austrian Academy of Sciences), Éric Lefebvre(Pinnacle Clinical Research), Philipp Schwabl(Austrian Academy of Sciences), Tatjana Stojaković, Johanna Schaub, Ksenia Brusilovskaya(Austrian Academy of Sciences)
Cited by 0
Related Papers
A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
|Hepatology|2017|657
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
|Hepatology|2017|550
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239